Information about Deraphar
My details
*
*
*

Deraphar (SRL)

BE 0439.109.003

Grote Markt 44, 9060 Zelzate

Company information

Status
Active

Enterprise number

BE0439.109.003

VAT liability
Yes
Established
04-12-1989
Last balance sheet year
2024
Company size
Small 2,1 FTE
Principal activity
Retail sale of pharmaceutical products
Health barometer
Credit limit
Detailpage

Are you looking for more information about this company?

  • Consult health at a glance

  • Choose quick insights or granular details

  • Get updates on important developments

Try for free Discover more

7-day free trial, no credit card required.

Financial data from Deraphar

2024 2023 2022 2021
Profit/Loss € 3,538 -74 % € 13,744 115 % € -90,789 -228 % € 71,200
Equity € 358,308 1 % € 354,770 4 % € 341,026 -21 % € 431,815
Gross margin € 191,616 -6 % € 202,979 124 % € 90,576 -61 % € 235,191
Employees 2.1 1.9 2.4 2.9

Publications from Deraphar

Date Publication
23-06-2022 Articles of Association (Translation, Coordination, Other Modifications, …) - Modification Legal Form - Designation - Goal - Resignations - Appointments - General meeting (NL)
09-02-2017 Resignations - Appointments (NL)
14-09-2011 Resignations - Appointments (NL)
25-07-2011 Resignations - Appointments (NL)
08-03-2001 Appointment(s) (NL)

Frequently asked questions

What is the VAT number of Deraphar?
The VAT number of Deraphar is BE 0439.109.003.
Wat is the PEPPOL ID of Deraphar?
The PEPPOL ID of Deraphar is 0208:0439109003. Log in or start a free trial to see the full overview.
When was Deraphar founded?
Deraphar was founded on 04-12-1989.
What is the address of Deraphar?
The current registered office of Deraphar is located at Grote Markt 44, 9060 Zelzate.
When was the last time Deraphar filed their annual financial statements?
The most recent financial statements of Deraphar were filed on 18-07-2025.
How many employees does Deraphar have?
There are 2,1 FTEs working at Deraphar according to the staff figures in the most recent financial statements.
What is the annual turnover of Deraphar?
At the time of its most recent financial statements, Deraphar did not publish any turnover figures. Deraphar reported a gross margin of €191,615.69.

Sources